Frank, Fabrice https://orcid.org/0000-0002-6524-4570
Florens, Nans https://orcid.org/0000-0002-0960-6055
Meyerowitz-katz, Gideon https://orcid.org/0000-0002-1156-9345
Barriere, Jérôme https://orcid.org/0000-0003-1113-8948
Billy, Éric https://orcid.org/0000-0002-8859-0089
Saada, Véronique https://orcid.org/0000-0001-8021-9050
Samuel, Alexander https://orcid.org/0000-0003-4547-5280
Robert, Jacques https://orcid.org/0000-0003-4380-1476
Besançon, Lonni https://orcid.org/0000-0002-7207-1276
Article History
Received: 13 February 2023
Accepted: 22 May 2023
First Online: 3 August 2023
Change Date: 9 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s41073-025-00162-2
Declarations
:
: Not applicable.
: Not applicable.
: AS and LB are both involved in separate legal proceedings with D Raoult who has been named in this article, both court trials are pending (as of May 2025). EB is a full-time Novartis employee and his views are his own. The remaining authors have no competing interests to declare.